Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

    Receive Latest News

    Share Us

    HEALTHCARE TRAINING 2021 - Regulatory Challenges of Real-world Artificial Intelligence (AI) and Machine Learning (ML)

    View: 116

    Website | Edit Freely


    Deadline: March 09, 2021 | Date: March 09, 2021

    Venue/Country: Online event, U.S.A

    Updated: 2021-01-15 15:59:00 (GMT+9)

    Call For Papers - CFP


    This session will provide insights on moving from the traditional regulatory strategies for mature technologies to the new regulatory strategies for novel uses of AI and ML while engaging FDA and/or Notified Bodies in the effort. The IMDRF, US and EU perspectives on what's next for AI and ML as SaMD will be explored.

    Why you should Attend: This session will engage professionals looking to understand the regulatory challenges of software as a medical device (SaMD) with special focus on AI/Machine Learning (ML).

    Areas Covered in the Session:

    Describe actual and future AI applications that are changing patient treatment and healthcare delivery through the exploration of real-world examples (across different diagnostic/therapeutic and technology areas)

    Demonstrate knowledge of US and EU perspectives on current developments and challenges stemming from the development and implementation of AI/ML in development of regulatory strategies

    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.